The platform was optimized for Interferon-gamma (IFNγ) detection, a common biomarker for M. tuberculosis infection and autoimmune diseases, using an immunofluorescence assay, achieving an impressive 500fg/mL limit of detection, outperforming that of ELISA, 2pg/mL. The gene discussed is IFNG; the disease is autoimmune disease.